Free Trial

Abeona Therapeutics (ABEO) Competitors

Abeona Therapeutics logo
$5.75 -0.14 (-2.38%)
Closing price 07/7/2025 04:00 PM Eastern
Extended Trading
$5.79 +0.04 (+0.70%)
As of 07/7/2025 05:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

ABEO vs. VRDN, BGM, MNKD, NAGE, LQDA, PCRX, ABCL, WVE, NVAX, and NTLA

Should you be buying Abeona Therapeutics stock or one of its competitors? The main competitors of Abeona Therapeutics include Viridian Therapeutics (VRDN), BGM Group (BGM), MannKind (MNKD), Niagen Bioscience (NAGE), Liquidia Technologies (LQDA), Pacira BioSciences (PCRX), AbCellera Biologics (ABCL), WAVE Life Sciences (WVE), Novavax (NVAX), and Intellia Therapeutics (NTLA). These companies are all part of the "med - biomed/gene" industry.

Abeona Therapeutics vs. Its Competitors

Abeona Therapeutics (NASDAQ:ABEO) and Viridian Therapeutics (NASDAQ:VRDN) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their analyst recommendations, risk, dividends, profitability, earnings, institutional ownership, media sentiment and valuation.

Abeona Therapeutics has a beta of 1.51, meaning that its share price is 51% more volatile than the S&P 500. Comparatively, Viridian Therapeutics has a beta of 0.39, meaning that its share price is 61% less volatile than the S&P 500.

80.6% of Abeona Therapeutics shares are owned by institutional investors. 5.4% of Abeona Therapeutics shares are owned by insiders. Comparatively, 0.7% of Viridian Therapeutics shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Abeona Therapeutics has higher revenue and earnings than Viridian Therapeutics. Abeona Therapeutics is trading at a lower price-to-earnings ratio than Viridian Therapeutics, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Abeona Therapeutics$3.50M84.05-$63.73M-$1.27-4.53
Viridian Therapeutics$300K4,321.55-$269.95M-$3.85-4.13

Abeona Therapeutics has a net margin of 0.00% compared to Viridian Therapeutics' net margin of -102,092.39%. Viridian Therapeutics' return on equity of -70.61% beat Abeona Therapeutics' return on equity.

Company Net Margins Return on Equity Return on Assets
Abeona TherapeuticsN/A -118.82% -52.48%
Viridian Therapeutics -102,092.39%-70.61%-44.67%

Abeona Therapeutics presently has a consensus target price of $19.25, suggesting a potential upside of 234.78%. Viridian Therapeutics has a consensus target price of $37.56, suggesting a potential upside of 136.35%. Given Abeona Therapeutics' stronger consensus rating and higher possible upside, equities research analysts plainly believe Abeona Therapeutics is more favorable than Viridian Therapeutics.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Abeona Therapeutics
0 Sell rating(s)
0 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
3.00
Viridian Therapeutics
0 Sell rating(s)
1 Hold rating(s)
9 Buy rating(s)
0 Strong Buy rating(s)
2.90

In the previous week, Abeona Therapeutics had 7 more articles in the media than Viridian Therapeutics. MarketBeat recorded 9 mentions for Abeona Therapeutics and 2 mentions for Viridian Therapeutics. Viridian Therapeutics' average media sentiment score of 0.87 beat Abeona Therapeutics' score of 0.26 indicating that Viridian Therapeutics is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Abeona Therapeutics
1 Very Positive mention(s)
0 Positive mention(s)
8 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Viridian Therapeutics
1 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Summary

Abeona Therapeutics beats Viridian Therapeutics on 10 of the 16 factors compared between the two stocks.

Get Abeona Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for ABEO and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ABEO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ABEO vs. The Competition

MetricAbeona TherapeuticsMED IndustryMedical SectorNASDAQ Exchange
Market Cap$301.31M$2.91B$5.52B$9.02B
Dividend YieldN/A2.44%5.24%4.08%
P/E Ratio-4.5320.3027.1920.04
Price / Sales84.05250.76395.22100.83
Price / CashN/A41.7026.2128.59
Price / Book5.697.397.925.55
Net Income-$63.73M-$55.04M$3.17B$248.49M
7 Day Performance3.23%2.51%1.79%4.87%
1 Month Performance-14.69%-0.21%1.28%6.63%
1 Year Performance19.79%3.41%33.32%20.38%

Abeona Therapeutics Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ABEO
Abeona Therapeutics
3.9812 of 5 stars
$5.75
-2.4%
$19.25
+234.8%
+26.7%$301.31M$3.50M-4.5390
VRDN
Viridian Therapeutics
1.7843 of 5 stars
$13.98
-2.4%
$37.56
+168.6%
+29.0%$1.17B$300K0.0050News Coverage
BGM
BGM Group
N/A$10.59
-11.5%
N/AN/A$1.16B$25.10M0.00298News Coverage
Analyst Downgrade
MNKD
MannKind
2.5173 of 5 stars
$3.74
-0.5%
$10.33
+176.3%
-31.0%$1.14B$285.50M37.40400Negative News
NAGE
Niagen Bioscience
1.293 of 5 stars
$14.41
+1.3%
$19.50
+35.3%
N/A$1.12B$99.60M158.00120
LQDA
Liquidia Technologies
3.2022 of 5 stars
$12.46
-4.9%
$26.89
+115.8%
+1.8%$1.12B$14M0.0050
PCRX
Pacira BioSciences
3.4122 of 5 stars
$23.90
+1.8%
$26.44
+10.6%
+10.3%$1.09B$700.97M10.34720Positive News
ABCL
AbCellera Biologics
2.4345 of 5 stars
$3.43
-5.0%
$8.33
+143.0%
+49.8%$1.08B$28.83M0.00500News Coverage
Analyst Forecast
High Trading Volume
WVE
WAVE Life Sciences
4.4187 of 5 stars
$6.50
-2.5%
$20.50
+215.4%
+29.1%$1.04B$108.30M-7.74240News Coverage
NVAX
Novavax
4.4691 of 5 stars
$6.30
-1.1%
$17.00
+169.8%
-44.5%$1.03B$682.16M2.381,990
NTLA
Intellia Therapeutics
4.704 of 5 stars
$9.38
-1.9%
$33.37
+255.7%
-55.0%$990.25M$57.88M0.00600

Related Companies and Tools


This page (NASDAQ:ABEO) was last updated on 7/8/2025 by MarketBeat.com Staff
From Our Partners